Regenicin Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	2017 - 2013
Period Ending	Jan '26 Jan 30, 2026	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	2017 - 2013
Market Capitalization	0	0	3	2	3	6	Upgrade
Market Cap Growth	-99.57%	-84.00%	66.67%	-36.84%	-51.41%	-34.83%	Upgrade
Enterprise Value	-	1	4	2	3	6	Upgrade
Last Close Price	0.00	0.00	0.02	0.01	0.02	0.04	Upgrade
PB Ratio	0.00	-0.09	-0.62	-0.43	-0.78	-2.00	Upgrade
Debt / Equity Ratio	-0.10	-0.11	-0.12	-0.13	-0.12	-0.12	Upgrade
Net Debt / Equity Ratio	1.81	-0.11	-0.12	-0.13	-0.12	-0.12	Upgrade
Quick Ratio	0.66	0.00	0.00	0.00	0.00	0.00	Upgrade
Current Ratio	0.66	0.00	0.00	0.00	0.00	0.02	Upgrade
Return on Assets (ROA)	-9.43%	-3738.30%	-9083.77%	-8774.17%	-1491.05%	-683.91%	Upgrade
Return on Capital Employed (ROCE)	14.40%	10.70%	12.80%	15.50%	19.80%	26.30%	Upgrade
Earnings Yield	-6420.32%	-130.16%	-21.85%	-30.38%	-26.01%	-9.32%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.